Lataa...
Narrative review: the holy grail: update on pharmacotherapy for heart failure with preserved ejection fraction
Heart failure with preserved ejection fraction (HFpEF) is the presence of clinical signs and/or symptoms of heart failure with a left ventricular ejection fraction (LVEF) ≥50%. Risk factors associated with this disease include hypertension, hyperlipidemia, atrial fibrillation (AF), obesity, diabetes...
Tallennettuna:
| Julkaisussa: | Ann Transl Med |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
AME Publishing Company
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8039660/ https://ncbi.nlm.nih.gov/pubmed/33850920 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm-20-4602 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|